Argent Biopharma Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 0.379x

Argent Biopharma Ltd cash flow conversion efficiency. Based on the latest financial reports, Argent Biopharma Ltd (RGT) has a cash flow conversion efficiency ratio of 0.379x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.27 Million ≈ $-2.31 Million USD) by net assets (AU$-8.63 Million ≈ $-6.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Argent Biopharma Ltd (2006–2023)

Cash flow conversion efficiency of Argent Biopharma Ltd from 2006 to 2023. This chart illustrates how Argent Biopharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RGT stock price for real-time trading data and today's change.

Argent Biopharma Ltd Cash Flow Conversion Ratio Explained

Argent Biopharma Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Argent Biopharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Argent Biopharma Ltd ranked by their cash flow conversion efficiency. Also see how much is Argent Biopharma Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
MOBA Network publ AB ST:MOBA	0.084x
CPD SA WAR:CPD	-0.023x
Panther Metals Ltd AU:PNT	-0.034x
Fintech Select Ltd V:FTEC	-0.753x
MW Trade S.A. WAR:MWT	-0.050x
Northern 2 Vct Plc LSE:NTV	-0.022x
Arctic Star Exploration Corp V:ADD	-0.015x
Vintage Energy Ltd AU:VEN	0.191x

Annual Cash Flow Conversion Efficiency for Argent Biopharma Ltd (2006–2023)

The table below shows the annual cash flow conversion efficiency of Argent Biopharma Ltd from 2006 to 2023. Review RGT FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-06-30	AU$-8.03 Million ≈ $-5.68 Million	AU$-11.99 Million ≈ $-8.48 Million	1.492x	+163.57%
2022-06-30	AU$5.18 Million ≈ $3.67 Million	AU$-12.16 Million ≈ $-8.60 Million	-2.347x	-170.67%
2021-06-30	AU$13.83 Million ≈ $9.78 Million	AU$-11.99 Million ≈ $-8.48 Million	-0.867x	+73.05%
2020-06-30	AU$3.09 Million ≈ $2.19 Million	AU$-9.96 Million ≈ $-7.05 Million	-3.218x	-446.82%
2019-06-30	AU$10.80 Million ≈ $7.64 Million	AU$-6.35 Million ≈ $-4.50 Million	-0.588x	-26.86%
2018-06-30	AU$12.69 Million ≈ $8.98 Million	AU$-5.89 Million ≈ $-4.17 Million	-0.464x	-57.30%
2017-06-30	AU$15.79 Million ≈ $11.17 Million	AU$-4.66 Million ≈ $-3.29 Million	-0.295x	-7.40%
2016-06-30	AU$11.73 Million ≈ $8.30 Million	AU$-3.22 Million ≈ $-2.28 Million	-0.275x	+14.35%
2015-06-30	AU$1.93 Million ≈ $1.36 Million	AU$-617.71K ≈ $-437.07K	-0.321x	-208.50%
2014-06-30	AU$4.55 Million ≈ $3.22 Million	AU$-472.74K ≈ $-334.49K	-0.104x	-54.01%
2013-06-30	AU$7.94 Million ≈ $5.62 Million	AU$-536.08K ≈ $-379.31K	-0.067x	+86.00%
2012-06-30	AU$787.42K ≈ $557.15K	AU$-379.45K ≈ $-268.48K	-0.482x	-17.80%
2011-06-30	AU$828.30K ≈ $586.08K	AU$-338.82K ≈ $-239.74K	-0.409x	-223.14%
2010-06-30	AU$-3.14 Million ≈ $-2.22 Million	AU$-1.04 Million ≈ $-737.66K	0.332x	-99.30%
2009-06-30	AU$-8.79K ≈ $-6.22K	AU$-416.04K ≈ $-294.38K	47.331x	+20017.04%
2008-06-30	AU$1.94 Million ≈ $1.37 Million	AU$-460.26K ≈ $-325.67K	-0.238x	+44.28%
2007-06-30	AU$3.81 Million ≈ $2.70 Million	AU$-1.63 Million ≈ $-1.15 Million	-0.426x	-2973.25%
2006-06-30	AU$2.76 Million ≈ $1.95 Million	AU$41.00K ≈ $29.01K	0.015x	--

About Argent Biopharma Ltd

AU:RGT Australia Drug Manufacturers - Specialty & Generic

Market Cap

$1.73 Million

AU$2.44 Million AUD

Market Cap Rank

#30175 Global

#1755 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.09

All Time High

AU$125.00